Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 12, 2008, Pages 2067-2074

  Chauleur, C ^a,b   Cochery Nouvellon, E ^a,c   Mercier, E ^a,c,d   Aya, G ^a,c   Fabbro Peray, P ^a   Mismetti, P ^b   Lissade Lavigne, G ^a,c   Gris, Jean Christophe ^a,c,d,e  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b University Jean Monnet of Saint Etienne EA3065   (France)

^c Research Group EA2992   (France)

^d UNIV MONTPELLIER   (France)

^e DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Hemorrhage; Hemostasis; Postpartum hemorrhage; Pregnancy

Indexed keywords

BLOOD CLOTTING FACTOR 9; FIBRINOGEN; FIBRINOGEN RECEPTOR; FRESH FROZEN PLASMA; GLYCOPROTEIN IB ALPHA; PADGEM PROTEIN; PROTHROMBIN; SULPROSTONE; THROMBIN RECEPTOR ACTIVATING PEPTIDE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD GROUP O; CASE CONTROL STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; FLUID THERAPY; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; POPULATION DISTRIBUTION; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ABO BLOOD-GROUP SYSTEM; ADULT; BIOLOGICAL MARKERS; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FEMALE; HEMOSTASIS; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICAL DISTRIBUTIONS; YOUNG ADULT;

EID: 56749098294     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2008.03168.x     Document Type: Article

References (26)

1. Zhang WH, Alexander S, Bouvier-Colle MH, Macfarlane A The MOMS-B Group. Incidence of severe pre-eclampsia, postpartum haemorrhage as a surrogate marker for severe maternal morbidity in a European population-based study: The MOMS-B survey. BJOG 2005; 102: 89-96.
2. Hazra S, Chilaka VN, Rajendran S, Konje JC. Massive postpartum haemorrhage as a cause of maternal morbidity in a large tertiary hospital. J Obstet Gynaecol 2004; 24: 519-20.
3. Deneux-Tharaux C, Dreyfus M, Goffinet F, Lansac J, Lemery D, Parant O, Chauveaud A, Bréart G, Bouvier-Colle MH le groupe Euphrates. Prevention and early management of immediate postpartum haemorrhage: Policies in six perinatal networks in France. J Gynecol Obstet Biol Reprod (Paris) 2008; 37: 237-45.
4. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105: 314-21.
5. Lee CA, Chi C, Pavord SR, Bolton-Maggs PHB, Pollard D, Hinchcliffe-Wood A, KAdir RA. The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK haemophilia centre doctors'organization. Haemophilia 2006; 12: 301-36.
6. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, Sibony O, Mahieu-Caputo D, Hurtaud-Roux MF, Huisse MG, Denninger MH, de Prost D For the PPH Study Group. The decrease of fibrinogen is an early predictor of the severity of postpartum haemorrhage. J Thromb Haemost 2006; 5: 266-73.
7. Lissalde-Lavigne G, Fabbro-Peray P, Cochery-Nouvelon E, Mercier E, Ripart-Neveu S, Balducchi JP, Daurès JP, Perneger T, Quéré I, Dauzat M, Marès P, Gris JC. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: The matched case-control "NOHA First" study. J Thromb Haemost 2005; 3: 2178-84.
8. Cochery-Nouvellon E, Mercier E, Lissalde-Lavigne G, Daurès JP, Quéré I, Dauzat M, Marès P, Gris JC. Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for thrombosis during the first pregnancy. J Thromb Haemost 2007; 4: 700-7.
9. Chauleur C, Cochery-Nopuvellon E, Mercier E, Aya G, Marès P, Mismetti P, Lissalde-Lavigne G, Gris JC. Analysis of the venous thromboembolic risk associated with severe postpartum haemorrhage in the NOHA First cohort. Thromb Haemost 2008; DOI 10.1160/TH08-06-0376.
10. Langer B, Bourdier E, Haberstish R, Dreyfus M. Obstetrical management in the event of persistent or worsening postpartum haemorrhage despite initial measures [French]. J Gynecol Obstet Biol Reprod 2004; 33: 4S73-9.
11. Dahlman T, Hellgren M, Blombäck M. Changes in blood coagulation and fibrinolysis in the normal puerperium. Gynecol Obstet Invest 1985; 20: 37-44.
12. Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Haemost 2003; 29: 125-30.
13. Blombäck M, Konkle BA, Manco-Johnson MJ, Bremme K, Hellgren M, Kaaja R On behalf of the ISTH SSC subcommittee on women's health issues. Prenanlytical conditions that affect coagulation testing, including hormonal status and therapy. J Thromb Haemost 2007; 5: 855-8.
14. Walsh PN. Platelet coagulation-protein interactions. Semin Thromb Haemost 2004; 30: 461-71.
15. Baglia FA, Shrimton CN, Emsley J, Kitagawa K, Ruggeri ZM, Lopez JA, Walsh PN. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelets. J Biol Chem 2004; 19: 49323-9.
16. Canobbio I, Balduini C, Torti M. Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal 2004; 16: 1329-44.
17. Lindqvist PG, Svensson PJ, Dahlbäck B, Marsal K. Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss - a possible evolutionary selection mechanism. Thromb Haemost 1998; 79: 69-73.
18. Clark P, Walker ID, Govan L, Wu O, Greer I. The GOAL study: A prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol 2008; 140: 236-40.
19. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO group on the diagnosis of von Willebrand disease. Blood 1987; 6: 1691-5.
20. Sadler JE. Von Willebrand disease 1: A diagnosis in search of a disease. Blood 2003; 101: 2089-93.
21. Kadir RA, Economides DL, Lee CA. Factor XI deficiency in women. Am J Hematol 1999; 60: 48-54.
22. Condie RG. A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by preeclampsia. Br J Obstet Gynecol 1976; 83: 636-9.
23. Hilgartner MW, Smith CH. Plasma thromboplastin antecedent (factor XI) in neonate. J Paediatr 1956; 66: 747-52.
24. Nossel HL, Lanzkowsky P, Levy S, Mibashan RS, Hansen JD. A study of coagulation factor levels in women during labour and in their newborn infants. Thromb Diath Haemorrh 1966; 16: 185-97.
25. Haubelt AL, Andres C, Vogt A, Hoerdt P, Seyfert UT, Hellstern P. Variables influencing Platelet Function Analyzer-100TM closure times in healthy individuals. Br J Haematol 2005; 130: 759-67.
26. Philipp CS, Miller CH, Faiz A, Dilley A, Michaels LA, Ayers C, Bachmann G, Dowling N, Saidi P. Screening of women with menorrhagia for underlying bleeding disorders: The utility of the platelet function analyser and bleeding time. Haemophilia 2005; 11: 497-503.